ĐÁNH GIÁ KẾT QUẢ ĐIỀU TRỊ VIÊM MŨI DO QUÁ PHÁT CUỐN MŨI DƯỚI BẰNG PHẪU THUẬT NỘI SOI BẺ CUỐN MŨI KẾT HỢP ĐỐT LASER CO2 TẠI BỆNH VIỆN TRƯỜNG ĐẠI HỌC Y DƯỢC CẦN THƠ NĂM 2025-2026

Abstract

 Background: Chronic rhinitis may lead to inferior turbinate hypertrophy that is refractory to medical treatment and requires surgical intervention to achieve long-term symptom relief. Objectives: 1. To describe the clinical and paraclinical characteristics of patients with inferior turbinate hypertrophy indicated for surgery at CanTho University of Medicine and Pharmacy Hospital from 2025 – 2026; 2. To evaluate the effectiveness of CO₂ laser surgery and out-fracture of the inferior turbinate hypertrophy at CanTho University of Medicine and Pharmacy Hospital from 2025 - 2026. Materials and methods: Twenty-three patients aged 18 years or older underwent CO₂ laser surgery and out-fracture of hypertrophic inferior turbinate at CanTho University of Medicine and Pharmacy Hospital from July 2025 to February 2026. A prospective interventional case-series study without a control group was conducted. Results: The operative time was less than 30 minutes in 56.5% of patients. Severe nasal obstruction was observed in 65.2% of patients, whereas 34.8% had moderate nasal obstruction. The average NOSE score before surgery was 65.6 ± 12.17, and 3 months after surgery was 4.5 ± 5.01. No intraoperative complications occurred in 91.4% of patients. Complete postoperative wound healing was observed in all patients (100%) at 3 months. Reduction in inferior turbinate size was observed in 87.1% of patients. No postoperative nasal crusting or turbinate osteitis was observed. Conclusions: CO₂ laser treatment combined with inferior turbinate out-fracture appears to be a safe and effective minimally invasive procedure for reducing inferior turbinate volume. The technique significantly improves nasal obstruction while preserving normal nasal physiological function, resulting in favorable short-term outcomes and a low complication rate.